Prevalence of the Clostridium difficile BI/NAP1/027 strain across the United States Veterans Health Administration SE Giancola, RJ Williams II, CA Gentry Clinical Microbiology and Infection 24 (8), 877-881, 2018 | 69 | 2018 |
Long-term hydroxychloroquine use in patients with rheumatic conditions and development of SARS-CoV-2 infection: a retrospective cohort study CA Gentry, MB Humphrey, SK Thind, SC Hendrickson, G Kurdgelashvili, ... The Lancet Rheumatology, 2020 | 54 | 2020 |
Fidaxomicin versus oral vancomycin for severe Clostridium difficile infection: a retrospective cohort study CA Gentry, PK Nguyen, S Thind, G Kurdgelashvili, GH Skrepnek, ... Clinical Microbiology and Infection 25 (8), 987-993, 2019 | 32 | 2019 |
Use of Novel Strategies to Develop Guidelines for Management of Pyogenic Osteomyelitis in Adults B Spellberg, G Aggrey, MB Brennan, B Footer, G Forrest, F Hamilton, ... Jama Network Open 5 (5), e2211321, 2022 | 30 | 2022 |
Clinical outcomes of fidaxomicin vs oral vancomycin in recurrent Clostridium difficile infection JD Tieu, RJ Williams II, GH Skrepnek, CA Gentry Journal of Clinical Pharmacy and Therapeutics, 1-9, 2018 | 15 | 2018 |
A propensity-matched analysis between standard versus tapered oral vancomycin courses for the management of recurrent Clostridium difficile infection CA Gentry, SE Giancola, S Thind, G Kurdgelashvili, GH Skrepnek, ... Open Forum Infectious Diseases, 2017 | 14 | 2017 |
Diabetic foot infections: an update on treatment EB Chahine, S Harris, R Williams US Pharm 38 (4), 23-26, 2013 | 12 | 2013 |
Outcomes associated with recent guideline recommendations removing metronidazole for treatment of non-severe Clostridioides difficile infection: a retrospective, observational … CA Gentry, DL Campbell, RJ Williams International Journal of Antimicrobial Agents 57 (3), 106282, 2021 | 10 | 2021 |
Evaluation of fidaxomicin usage patterns and outcomes for Clostridium difficile infection across the United States Veterans Health Administration SE Giancola, RJ Williams, CA Gentry Journal of clinical pharmacy and therapeutics 43 (3), 353-358, 2018 | 7 | 2018 |
Trends in Susceptibility Rates and Extended-Spectrum β-Lactamase Production of Klebsiella pneumoniae in Bloodstream Infections Across the United States Veterans Affairs … CA Gentry, RJ Williams II Microbial Drug Resistance 21 (6), 590-599, 2015 | 7 | 2015 |
Increased antimicrobial susceptibility rates for Pseudomonas aeruginosa bloodstream isolates across the Veterans Affairs Healthcare System CA Gentry, RJ Williams II Diagnostic Microbiology and Infectious Disease 82 (3), 215-221, 2015 | 6 | 2015 |
Continued decline in the prevalence of the Clostridioides difficile BI/NAP1/027 strain across the United States Veterans Health Administration CA Gentry, RJ Williams II, D Campbell Diagnostic microbiology and infectious disease 100 (2), 115308, 2021 | 5 | 2021 |
A propensity score-matched analysis of the impact of minimum inhibitory concentration on mortality in patients with Pseudomonas aeruginosa bacteraemia treated with piperacillin … CA Gentry, RJ Williams II International Journal of Antimicrobial Agents, 2017 | 5 | 2017 |
Propensity-matched analysis of the protective effect of ticagrelor versus clopidogrel on the risk of developing Staphylococcus aureus bacteremia CA Gentry, CM Whitman, BS Kliewer, RJ Williams II, SK Thind International Journal of Antimicrobial Agents 61 (4), 106752, 2023 | 4 | 2023 |
A Propensity Score-Matched Analysis of the Impact of Minimum Inhibitory Concentration on Mortality in Patients with Pseudomonas aeruginosa Bacteremia Treated with Cefepime or … AR Ratliff, CA Gentry, RJ Williams Diagnostic Microbiology and Infectious Disease 87 (4), 376-381, 2017 | 3 | 2017 |
Staphylococcus aureus bacteraemia treatment outcomes in patients receiving ticagrelor vs a propensity-matched cohort receiving clopidogrel CA Gentry, RJ Williams II, CM Whitman, SK Thind, BS Kliewer International Journal of Antimicrobial Agents 61 (4), 106743, 2023 | | 2023 |
Development of SARS-CoV-2 infection in patients with rheumatic conditions on hydroxychloroquine monotherapy vs. patients without rheumatic conditions: A retrospective … CA Gentry, SK Thind, RJ Williams II, SC Hendrickson, G Kurdgelashvili, ... The American Journal of the Medical Sciences 365 (1), 19-25, 2023 | | 2023 |